Dudediligence.

Inhibikase Therapeutics, Inc

IKTNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Reported ·

$2,999,999

0 sales · 1 buy

Oct 2025 to Sep 2026

REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2025-11-21: Sands Capital Alternatives, LLC, bought
under a no plan named▲ buysize is dollars

Form 4 filings, newest first

2025-11-21Sands Capital Alternatives, LLC$2,999,999
▲ bought2,068,965 shno plan namedForm 4 ↗